Clinical Trial Detail

NCT ID NCT03190278
Title Study Evaluating Safety and Efficacy of UCART123 in Patients With Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectis S.A.
Indications

acute myeloid leukemia

Therapies

UCART123

Age Groups: adult senior

No variant requirements are available.